Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales @ radiantinsights. com Web: http:// www. radiantinsights. com /
�
Identify commercial opportunities in the respiratory disorder deals landscape by analyzing trends in licensing and co-development deals, and by profiling the most significant deals that have occurred in this indication in recent years.
Browse Other Reports of This Category at: http:// www. radiantinsights. com / catalog / pharmaceuticals-and-healthcare
Table of Contents:
1. Introduction 10 2. Key Marketed Products 36 3. Pipeline Landscape Assessment 56 4. Multi-scenario Market Forecast to 2022 75 5. Company Analysis and Positioning 92 6. Strategic Consolidations 109
List of Tables:
� Table 1: Respiratory Disorders Therapeutics Market, Global, Epidemiology, 2016 11
� Table 2: Respiratory Disorders Therapeutics Market, Global, Classification of Asthma Severity in Children of 0-4 Years of Age 25
� Table 3: Respiratory Disorders Therapeutics Market, Global, Classification of Asthma Severity in Children of 5-11 Years of Age 26
� Table 4: Respiratory Disorders Therapeutics Market, Global, Classification of Asthma Severity in Youths of 12 Years or More and Adults 27
� Table 5: Respiratory Disorders Therapeutics Market, Global, COPD Disease Severity, 2016 28
� Table 6: Respiratory Disorders Therapeutics Market, Global, COPD Patient Risk Categories, 2016 29
� Table 7: Respiratory Disorders Therapeutics Market, Global, IPF Severity Classification, 2016 29
� Table 8: Respiratory Disorders Therapeutics Market, Global, CF Severity Classification, 2016 31
� Table 9: Respiratory Disorders Therapeutics Market, Global, COPD Treatment Algorithm, 2016 33
� Table 10: Respiratory Disorders Therapeutics Market, Global, CF Treatment Plan, 2016 35
� Table 11: Respiratory Disorders Therapeutics Market, Global, Approved Indications for Advair, 2016 38
� Table 12: Respiratory Disorders Therapeutics Market, Global, Approved Indications for Spiriva, 2016 40
� Table 13: Respiratory Disorders Therapeutics Market, Global, Approved Indications for Symbicort, 2016 42
https
:// www. facebook. com / RadiantInsights
https:// www. linkedin. com / company / radiant-insights https:// twitter. com / radiantinsights
https:// plus. google. com /+ Radiantinsights